Furthermore, our current findings suggest that the expression of tumor cell-intrinsic cGAS–STING, along with MMR/MSI status, could be a novel biomarker predicting the efficacy of immunotherapy using ICIs in GC. This evidence concerns the gene CGAS and neoplasm.